Head and neck malignancy: An overview

Principles and Practice of Head and Neck Surgery and Oncology, Second Edition

Volumn , Issue , 2009, Pages 1-13

  Balfour, Alistair ^a   Evans, Peter H Rhys ^b   Patel, Snehal G ^c,d  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883552850     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (82)

1. Curado MP, Edwards B, Shin HR et al, eds. Cancer Incidence in Five Continents, Vol. IX (IARC Scientific Publications, No. 160). Lyon: IARC, 2007.
2. American Cancer Society. Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society, 2007.
3. Office of National Statistics (ONS). Cancer Statistics 2000: Registrations Series MB1 - No 31. London: The Stationery Office, 2003.
4. Welsh Cancer Intelligence and Surveillance Unit. Cancer incidence in Wales 1992-2001. 2002 www.wcisu.wales.nhs.uk
5. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide (IARC CancerBase No. 5. version 2.0). Lyon: IARC Press, 2004. http://www-dep.iarc.fr/
6. Stewart BW, Kleihues P, eds. World Cancer Report. Lyon: IARC Press, 2003.
7. Swerdlow A, dos Santos Silva I, Doll R. Cancer incidence and mortality in England and Wales: trends and risk factors. Oxford University Press, 2001.
8. Mackillop WJ, Zhang-Salomons J, Boyd CJ, Groome PA. Associations between community income and cancer incidence in Canada and the United States. Cancer 2000; 89: 901-12.
9. Quinn MJ, Babb P, Brock A, Kirby L, Jones J. Cancer Trends in England and Wales 1950-1999. Studies on Medical and Population Subjects (Office of Population Censuses and Surveys, No. 66). London: The Stationery Office, 2001.
10. Coleman MP, Babb P, Damiecki P et al. Cancer Survival Trends in England and Wales 1971-1995: deprivation and NHS Region (Studies on Medical and Population Subjects, No. 61). London: The Stationery Office, 1999.
11. Maier H, De Vries N, Snow GB. Occupational factors in the aetiology of head and neck cancer. Clin Otolaryngol 1991; 16: 406-12.
12. Khan HA. The Dorn study of smoking and mortality among US veterans: report on 8 1/2 years of observation. J Natl Cancer Inst 1966; 19: 1896-1906.
13. Burch JD, Howe GR, Miller AB, Semenciw R. Tobacco, alcohol, asbestos and nickel in the etiology of cancer of the larynx: a case-control study. J Natl Cancer Inst 1981; 67: 1219-24.
14. Schantz SP, Zhang ZF, Spitz MS et al. Genetic susceptibility to head and neck cancer: interaction between nutrition and mutagen sensitivity. Laryngoscope 1997; 107: 765-81.
15. Jafek BW, Smith CM, Moran DT et al. Effects on the upper respiratory passages. Otolaryng Head Neck 1992; 106: 720-9.
16. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol 1989; 115: 621-5.
17. IARC. Tobacco Smoking (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38). Lyon: IARC Press, 1986.
18. IARC. Tobacco Smoke and Involuntary Smoking (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 83). Lyon: IARC Press, 2004.
19. Stell PM, McGill T. Asbestos and laryngeal carcinoma. Lancet 1973; 2: 416-17.
20. Stell PM, McGill T. Exposure to asbestos and laryngeal carcinoma. J Laryngol Otol 1975; 89: 513-17.
21. Zemla B, Wojcieszek Z. The epidemiological risk factors of the larynx cancer among the native and migrant male population. Neoplasma 1984; 31: 465-74.
22. Moulin JJ, Mur JM, Wild P et al. Oral cavity and laryngeal cancers among man-made mineral fibre production workers. Scand J Work Environ Health 1986; 12: 27-31.
23. Zagraniski RT, Kelsey JL, Walter SD. Occupational risk factors for laryngeal cancer: Connecticut, 1975-1980. Am J Epidemiol 1986; 124: 167-76.
24. Acheson ED, Cowdell H, Hadfield E, Macbeth RG. Nasal cancer in woodworkers in the furniture industry. Br Med J 1970; 2: 587-96.
25. Wynder EL, Covey LS, Mabuchi K, Mushinski M. Environmental factors in cancer of the larynx. A second look. Cancer 1976; 38: 1519-601.
26. Gerosa A, Turrini O, Bottasso F. Laryngeal cancer in a factory molding thermoplastic resins. Med Lav 1986; 77: 172-6.
27. Tabershaw IR, Gaffey WR. Mortality study of workers in the manufacture of vinyl chloride and its polymers. J Occup Med 1974; 16: 509-18.
28. Manning KP, Skegg DCG, Stell PM, Doll R. Cancer of the larynx and other occupational hazards of mustard gas workers. Clin Otolaryngol 1981; 6: 165-70.
29. Wolf O. Larynxkarzinome bei Naphtalinreinigern. Z Gesamte Hyg 1978; 24: 737-9.
30. Alderson MR, Ratten NS. Mortality of workers on an isopropyl alcohol plant and two MEK dewaxing plants. Br J Ind Med 1980; 37: 85-9.
31. Klayman MB. Exposure to insecticides. Arch Otolaryngol 1968; 88: 116-17.
32. Lynch J, Hanis NM, Bird MG et al. An association of upper respiratory cancer with exposure to diethyl sulfate. J Occup Med 1979; 211: 333-41.
33. Soskolne CL, Zeighami EA, Hanis NM et al. Laryngeal cancer and occupational exposure to sulfuric acid. Am J Epidemiol 1984; 120: 358-69.
34. Decoufle P. Cancer risk associated with employment in the leather and leather products industry. Arch Environ Health 1979; 34: 33-7.
35. Delager NA, Mason TJ, Fraumeni JF et al. Cancer mortality among workers exposed to zinc chromate paints. J Occup Med 1980; 22: 25-9.
36. Wynder EL, Bross IJ, Feldman RM. A study in etiological factors in cancer of the mouth. Cancer 1957; 10: 1300-23.
37. Schwartz E. Proportionate mortality ratio analysis of auto mechanics and gasoline service station workers in New Hampshire. Am J Ind Med 1987; 12: 91-9.
38. Pedersen E, Hogetveit AC, Andersen A. Cancer of the respiratory organs among workers at a nickel refinery in Norway. Int J Cancer 1982; 30: 681-5.
39. Flanders WD, Rothman KJ. Occupational risk of laryngeal cancer. Am J Public Health 1982; 72: 369-72.
40. Morris Brown L, Mason TJ et al. Occupational risk factors for laryngeal cancer on the Texas Gulf Coast. Cancer Res 1988; 48: 1960-4.
41. Nikiforov Y, Gnepp DR. Pediatric thyroid carcinoma after the Chernobyl disaster: pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer 1994; 74: 748-66.
42. Martland HS. Occurrence of malignancy in radioactive persons; a general review of data gathered in the study of radium dial painters, with special reference to the occurrence of osteogenic sarcoma and the interrelationship of certain blood diseases. Am J Cancer 1931; 15: 2435-516.
43. Patel SG, See ACH, Rhys Evans PH et al. Radiation induced sarcomas of the head and neck. Head Neck 1999; 7: 346-53.
44. Mark RJ, Bailet JW, Poen J et al. Post irradiation sarcoma of the head and neck. Cancer 1993; 72: 887-93.
45. Hall P. Radiation-induced thyroid cancer. Med Oncol Tumor Pharmacother 1992; 9: 183-4.
46. van Kaick G, Wesch H, Luhrs H et al. Neoplastic diseases induced by chronic alpha-irradiation - epidemiological, biophysical and clinical results of the German Thorotrast Study. J Radiat Res (Tokyo) 1991; 32: 20-33.
47. IARC. Human Papillomaviruses (IARC Monographs on the Evaluation of Carcinogenic risks to Humans, Vol. 90), Lyon: IARC Press, 2007.
48. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-75.
49. IARC. Epstein-Barr Virus and Kaposi’s Sarcoma Herpesvirus/Human Herpesvirus 8 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 70). Lyon: IARC Press, 1997.
50. Wake M. The urban/rural divide in head and neck cancer: the effect of atmospheric pollution. Clin Otolaryngology. 1993; 18: 298-302.
51. Kabat GC, Chang CJ, Wynder EL. The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol 1994; 23: 1137-44.
52. Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among US veterans. Cancer 1993; 72: 1369-75.
53. IARC. Alcohol drinking (IARC Monographs on the Evaluation of carcinogenic risks to Humans, Vol. 44). Lyon: IARC Press, 1988.
54. Blot WJ, McLaughlin JK, Winn DM et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-87.
55. IARC. Tobacco habits other than smoking; betelquid and areca-nut chewing; and some related nitrosamines (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 37). Lyon: IARCPress, 1985.
56. IARC. Smokeless Tobacco and Some Tobacco-specific N - nitrosamines (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 89). Lyon: IARC Press, 2007.
57. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. I Epidemiology. Cancer Causes Control 1991; 2: 325-57.
58. Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989; 49: 3713-21.
59. O’Brien PH, Carlson R, Steubner EA. Distant metastases in epidermoid cell carcinoma of the head and neck. Cancer 1927; 304: 1071.
60. Forssell G. Radiotherapy of malignant tumours in Sweden. Br J Radiol 1930; 3: 198-234.
61. Harrison DFN. Multimodal treatment and new approaches to therapy. In: Rhys Evans PH, Robin PE, Fielding JWL, eds. Head and Neck Cancer. Tunbridge Wells: Castle House Publications, 1983; 233-46.
62. Fletcher GH. Combination of irradiation and surgery. In: Fletcher GH, ed. Textbook of Radiotherapy, 3rd ed. Philadelphia: Lea and Febiger, 1980; 219-24.
63. McGregor IA. Fundamental Techniques of Plastic Surgery, 5th ed. Edinburgh: Churchill Livingstone, 1972.
64. Bakamjian VY. A two-stage method for pharyngoesophageal reconstruction with a primary pectoral skin flap. Plast Reconstr Surg 1965; 36: 173-84.
65. Ariyan S. The pectoralis major myocutaneous flap. A versatile flap for reconstruction in the head and neck. Plast Reconstr Surg 1979; 63: 73.
66. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71: 83-91.
67. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomised trials. J Clin Oncol 1996; 14: 838-47.
68. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Lancet 2000; 355: 949-55.
69. Hewitt HB, Blake ER. The growth of transplanted murien tumours in pre-irradiated sites. Br J Cancer 1968; 22: 808-24.
70. Robertson AG, Robertson C, Soutar DS et al. Treatment of oral cancer: the need for defined protocols and specialist centres. Variations in the treatment of oral cancer. Clin Oncol 2001; 13: 409-15.
71. Kowalski LP, Franco EL, Torloni H et al. Lateness of diagnosis of oral and oropharyngeal carcinoma: factors related to the tumour, the patient and health professionals. Eur J Cancer B Oral Oncol 1994; 30B: 167-73.
72. National Institute for Clinical Excellence. Improving Outcomes in Head and Neck Cancers. The Research eVidence (Guidance on cancer services). London: NICE, 2004. www.nice.org.uk
73. Khalil AA, Bentzen SM, Bernier J et al. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Int J Radiat Oncol 2003; 55: 568-75.
74. Kwong DL, Sham JS, Chua DT et al. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol 1997; 39: 703-10.
75. Huang J, Barbera L, Brouwers M et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003; 21: 555-63.
76. National Institute for Clinical Excellence. Improving outcomes in head and neck cancers (Guidance on cancer services). London: NICE, 2004. www.nice.org.uk
77. Coleman MP, Rachet B, Woods L et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004; 90: 1367-73.
78. O’Malley BW Jr, Weinstein GS, Snyder W, Hockstein NG. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006; 116: 1465-72.
79. Hanna EY, Holsinger C, DeMonte F, Kupferman M. Robotic endoscopic surgery of the skull base: a novel surgical approach. Arch Otolaryngol 2007; 133: 1209-14.
80. Ozer E, Waltonen J. Transoral robotic nasopharyngectomy: a novel approach for nasopharyngeal lesions. Laryngoscope 2008; 118: 1613-6.
81. Bonner JA, Harari PM, Giralt J et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-78.
82. Wang LX, Agulnik M. Promising newer moleculartargeted therapies in head and neck cancer. Drugs 2008; 68: 1609-19.